卡馬西平
別名: Tegretol, Carbatrol, Epitol, Equetro
藥物類別: Anticonvulsant / Neuropathic Pain Analgesic / Behavior Modifier
您的獸醫師為您的寵物開立了卡馬西平（Carbamazepine）。請仔細閱讀以下資訊： * **標示外使用（Off-Label Use）：** 此藥物在獸醫學中屬於「標示外使用」。它並不常用，您的獸醫師是根據您寵物特定的行為或神經系統需求而開立的。 * **嚴格遵守給藥時間：** 務必完全按照指示給藥。因為動物代謝這種藥物的速度非常快，漏服一次可能會導致藥效喪失。它通常需要頻繁給藥。 * **觀察事項：** 觀察您的寵物是否有嗜睡、步態不穩（共濟失調）或腸胃不適（嘔吐、食慾不振）的跡象。 > **重要提示：** 如果發現任何異常行為、嚴重嘔吐或眼睛/牙齦發黃（黃疸），請立即向您的獸醫師報告，因為這些可能是肝臟壓力或不良反應的徵兆。
劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
Veterinary professional? See the full dosing-by-species reference on VetSheet →
用途
- For photic head shaking
- As a psychotherapeutic agent
給藥方式
PO
可能的副作用
- Sedation and lethargy
- Ataxia (unsteadiness)
- Gastrointestinal upset (vomiting, anorexia)
- Hepatotoxicity (elevated liver enzymes)
- Blood dyscrasias (rare but possible bone marrow suppression)
注意事項與禁忌
- Patients receiving MAO Inhibitors (e.g., selegiline) within the past 14 days
- Patients with a history of bone marrow depression
- Known hypersensitivity to carbamazepine or tricyclic antidepressants
- Use with extreme caution due to extensive drug interactions (it is a potent inducer of hepatic enzymes). In dogs, it rapidly induces its own metabolism (autoinduction), making long-term therapeutic dosing difficult. May interfere with thyroid function tests (decreased values) and some pregnancy tests, though veterinary significance is unclear.
藥物相互作用
- Azole Antifungals (e.g., Ketoconazole, Itraconazole): May increase plasma levels or effects of carbamazepine
- Calcium Channel Blockers (e.g., Diltiazem, Verapamil): May increase plasma levels or effects of carbamazepine; Carbamazepine may also decrease their effects
- Cimetidine: May increase plasma levels or effects of carbamazepine
- Danazol: May increase plasma levels or effects of carbamazepine
- Grapefruit Juice: May increase plasma levels or effects of carbamazepine
- Isoniazid: May increase plasma levels or effects of carbamazepine; Carbamazepine may also increase effects of Isoniazid
- Macrolides (e.g., Erythromycin, Clarithromycin): May increase plasma levels or effects of carbamazepine
- MAO Inhibitors (e.g., Selegiline): Contraindicated; discontinue MAOI at least 14 days prior to carbamazepine
- Niacin: May increase plasma levels or effects of carbamazepine
- SSRI Antidepressants (e.g., Fluoxetine): May increase plasma levels or effects of carbamazepine
- Tricyclic Antidepressants (e.g., Clomipramine, Amitriptyline): May increase plasma levels or effects of carbamazepine; Carbamazepine may also decrease their effects, though it can increase Clomipramine levels
- Valproic Acid: May increase plasma levels or effects of carbamazepine; Carbamazepine may decrease its effects and increase risk for phenobarbital toxicity
- Barbiturates (e.g., Phenobarbital): May decrease plasma levels or effects of carbamazepine
- Cisplatin: May decrease plasma levels or effects of carbamazepine
- Doxorubicin: May decrease plasma levels or effects of carbamazepine
- Felbamate: May decrease plasma levels or effects of carbamazepine
- Phenytoin: May decrease plasma levels or effects of carbamazepine
- Primidone: May decrease plasma levels or effects of carbamazepine
- Rifampin: May decrease plasma levels or effects of carbamazepine
- Theophylline: May decrease plasma levels or effects of carbamazepine
- Acetaminophen: Carbamazepine may decrease its effect by lowering serum concentrations
- Benzodiazepines: Carbamazepine may decrease its effect by lowering serum concentrations
- Bupropion: Carbamazepine may decrease its effect by lowering serum concentrations
- Buspirone: Carbamazepine may decrease its effect by lowering serum concentrations
- Cyclosporine: Carbamazepine may decrease its effect by lowering serum concentrations
- Doxycycline: Carbamazepine may decrease its effect by lowering serum concentrations
- Glucocorticoids: Carbamazepine may decrease its effect by lowering serum concentrations
- Lamotrigine: Carbamazepine may decrease its effect by lowering serum concentrations
- Levothyroxine: Carbamazepine may decrease its effect by lowering serum concentrations
- Methadone: Carbamazepine may decrease its effect by lowering serum concentrations
- Mirtazapine: Carbamazepine may decrease its effect by lowering serum concentrations
- Non-depolarizing muscle blockers (e.g., Atracurium): Carbamazepine may decrease its effect by lowering serum concentrations
- Praziquantel: Carbamazepine may decrease its effect by lowering serum concentrations
- Topiramate: Carbamazepine may decrease its effect by lowering serum concentrations
- Tramadol: Carbamazepine may decrease its effect by lowering serum concentrations
- Zonisamide: Carbamazepine may decrease its effect by lowering serum concentrations
- Trazodone: Carbamazepine may decrease its effect by lowering serum concentrations
- Warfarin: Carbamazepine may decrease its effect by lowering serum concentrations
常見問題
卡馬西平用於寵物有甚麼用途？
您的獸醫師為您的寵物開立了卡馬西平（Carbamazepine）。請仔細閱讀以下資訊： • 標示外使用（Off-Label Use）： 此藥物在獸醫學中屬於「標示外使用」。它並不常用，您的獸醫師是根據您寵物特定的行為或神經系統需求而開立的。 • 嚴格遵守給藥時間： 務必完全按照指示給藥。因為動物代謝這種藥物的速度非常快，漏服一次可能會導致藥效喪失。它通常需要頻繁給藥。 • 觀察事項： 觀察您的寵物是否有嗜睡、步態不穩（共濟失調）或腸胃不適（嘔吐、食慾不振）的跡象。 > 重要提示： 如果發現任何異常行為、嚴重嘔吐或眼睛/牙齦發黃（黃疸），請立即向您的獸醫師報告，因為這些可能是肝臟壓力或不良反應的徵兆。
卡馬西平對我的寵物安全嗎？
劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
本文僅供一般健康教育，不能取代專業獸醫意見。如寵物身體不適，請諮詢獸醫。